Heron Therapeutics (HRTX) Scheduled to Post Quarterly Earnings on Tuesday

Heron Therapeutics (NASDAQ:HRTX) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, November 12th. Analysts expect the company to announce earnings of ($0.03) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Heron Therapeutics (NASDAQ:HRTX) last posted its earnings results on Tuesday, August 6th. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.02). The business had revenue of $36.02 million during the quarter, compared to analysts’ expectations of $35.35 million. During the same period last year, the firm posted ($0.35) earnings per share.

Heron Therapeutics Stock Down 3.9 %

Shares of NASDAQ:HRTX traded down $0.07 during midday trading on Tuesday, reaching $1.71. 346,938 shares of the company were exchanged, compared to its average volume of 2,396,292. The firm has a market cap of $259.36 million, a PE ratio of -5.42 and a beta of 1.81. The stock has a fifty day simple moving average of $1.88 and a two-hundred day simple moving average of $2.58. Heron Therapeutics has a fifty-two week low of $0.50 and a fifty-two week high of $3.93.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC reissued a “buy” rating and issued a $5.00 price objective on shares of Heron Therapeutics in a report on Wednesday, September 25th.

About Heron Therapeutics

Heron Therapeutics, Inc, a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration.